High Prevalence of Cancer to Boost Demand for Ultrasonic Aspirators in the United States

Ultrasonic aspirator is a surgical device that uses low frequency ultrasound energy to dissect or fragment tissues with low fiber content. It finds application in ultrasonic fragmentation, emulsification and aspiration of both soft and hard tissue. Neurosurgeons use a surgical aspirator to remove brain tumors without adversely affecting the surrounding healthy tissue.

Ultrasonic aspirator is a surgical device that uses low frequency ultrasound energy to dissect or fragment tissues with low fiber content. It finds application in ultrasonic fragmentation, emulsification and aspiration of both soft and hard tissue. Neurosurgeons use a surgical aspirator to remove brain tumors without adversely affecting the surrounding healthy tissue.

In the United States, high prevalence of cancer is expected to boost demand for ultrasonic aspirators. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Moreover, major manufacturers are focused on approval and launch of new devices. For instance, in July 2020, Integra LifeSciences Holdings Corporation received FDA clearance for a specific indication for neurosurgery for its (Cavitron Ultrasonic Surgical Aspirator) CUSA Clarity Ultrasonic Surgical Aspirator System. Manufacturers are also focused on launching products that allow surgeons to fragment, emulsify and aspirate soft tissue and bone during complex cranial neurosurgery, spinal and ear, nose and throat procedures. For instance, in April 2019, Stryker Corporation, launched its Sonopet iQ ultrasonic aspirator system and its SpineMapGo software at the American Association of Neurological Surgeons meeting in San Diego, California, U.S.